Can Urogen Pharma Urgn Stock Recover Now Urgn Q4 Earnings Misses Estimates By 0.03 20260410 1 Myriad Genetics MYGN Slips as Stock Navigates Support Levels Near 359 Apartment Investment and Management Company AIV Edges Higher as Key Support Holds Myers Industries MYE Surges 386 Approaching Resistance Amid Renewed Buying Interest FutureCrest Acquisition Corp FCRS Holds Steady at 1022 as Market Awaits Catalyst